Functional outcome after laser vaporisation of the prostate with the KTP laser;Funktionelle ergebnisse nach laservaporisation der prostata mit dem KTP-laser

Urologe - Ausgabe A

Volumn 46, Issue 5, 2007, Pages 521-527

  Hamann, M F ^a   Wild, C ^a   Seif, C ^a   Hautmann, S ^a   Junemann K P ^a   Braun, P M ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Benign prostatic hyperplasia; Laser vaporisation; Potassium titanyl phosphate; Urodynamic

Indexed keywords

POTASSIUM DERIVATIVE; POTASSIUM TITANYL PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER FUNCTION; BLADDER NECK STENOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; FOLLOW UP; HOSPITALIZATION; HUMAN; LOW LEVEL LASER THERAPY; MORBIDITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; QUALITY OF LIFE; SEXUAL FUNCTION; URINE FLOW RATE; URODYNAMICS; VAPORIZATION;

AGED; AGED, 80 AND OVER; CYSTOSCOPES; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; LENGTH OF STAY; MALE; MIDDLE AGED; PENILE ERECTION; POSTOPERATIVE COMPLICATIONS; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 34248345155     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1311-z     Document Type: Article

References (29)

1. Abrams P, Griffiths DJ (1979) The assesment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51: 129-134
2. Alschibaja M, May F, Treiber U et al. (2005) Transurethrale Resektion bei benigner Prostatahyperplasie. Aktuelle Entwicklungen. Urologe A 44: 499-504
3. Bachmann A, Reich O, Wyler S et al. (2004) Vaporisation of the prostate with the 80 W potassium titanyl phosphate (KTP) laser technique and 6 months follow-up after 70 procedures. Urologe A 43: 1262-1270
4. Bachmann A, Schurch L, Ruszat R et al. (2005) Photoselective Vaporisation (PVP) versus Transurethral Resektion of the Prostate (TURP): A prospective Bi-Center study of perioerative morbidity and early functional outcome. Eur Urol 48: 965-971
5. Chahal R, Sundaram SK, Gogoi NK (2000) Assessment of voiding outcome, sexual function and quality of life two years following KTP/YAG hybrid laser prostatectomy. Urol Int 65: 125-129
6. Chute CG, Panser LA, Girman CJ et al. (1993) The prevalence of prostatism population based survey of urinary symptoms. J Urol 150: 85-89
7. Hai MA, Malek RS (2003) Photoselective vaporisation of the prostate: initial experience with a new 80 W KTP laser fort he treatment of benign prostatic hyperplasia. J Endourol 17: 93-96
8. Hald T (1989) Urodynamics in benign prostatic hyperplasia. A survey. Prostate 2(Suppl): 69-77
9. Homma Y, Imaio C, Takahashi S et al. (1994) Urinary symptoms and urodynamics in a normal elderly population. Scand J Urol Nephrol 157(Suppl): 27-30
10. Jensen KM-E, Bruskewitz RC, Madsen PO (1984) Urodynamic findings in elderly males without prostatic complaints. Urology 24: 211-213
11. Kato K, Monson FC, Longhurst PA et al. (1990) The functional effects of long-term outlet obstruction on the rabbit urinary bladder. J Urol 143: 600-606
12. Kuntzmann RS, Malek RS, Barrett DM, Bostwick DG (1997) High-power (60-watt) titanyl-phophate laser vaporistation prostatektomie in living canines and in human and canin cadavers. Urology 49: 703-708
13. Kuntzmann RS, Malek RS, Barrett DM, Bostwick DG (1996) Potassium-titanyl-phophate laser vaporistation of the prostate: a comparative functional and pathologic study in canines. Urology 48: 575-583
14. Malek RS, Kuntzmann RS, Barrett DM (2005) Photoselective potassium-titanyl-phophate laser vaporistation of the benign obstructive prostate: observations on long-term outcomes. J Urol 174: 1344-1348
15. Mebust WK, Holgrewe HL, Cockett AT, Peters PC (2002) Transurethral prostatectomy: Immediate and posaoperative complications. A cooperative study of 13 participating institutions evaluating 3.885 patients. J Urol 167: 5-9
16. Samuelsson E, Mansson L, Milsom I (2001) Incontinence aids in Sweden: users and costs. BJU Int 88: 893-898
17. Muschter R (2001) Current status of laser treatment of benign prostatic hyperplasia. Med Laser Appl 16: 5-13
18. Muschter R, Hofstetter A (2000) Die interstitielle Laserkoagulation mit dem Diodenlaser der Wellenlänge 830 nm zur Therapie der benignen Prostatahyperplasie - High- versus Low-Volume-Koagulation. Lasermed 15: 72-80
19. Nitti VW, Kim Y, Combs AJ (1994) Correlation of the AUA syptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn 13: 521-529
20. Reek C, Conrad S, Heinzer H, Huland H (2001) Sidefire-Laserkoagulation der Prostata mit dem Neodym: YAG-Laser. Urol A 40: 127-132
21. Reich O, Bachmann A, Shneede P et al. (2004) Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 171: 2502-2504
22. Reich O, Bachmann A, Siebels M et al. (2005) High power (80 W) potassium-titanyl-phosphate laser vaporisation of the prostate in 66 high risk patients. J Urol 173: 158-160
23. Rosier PFWM, Rosette JJMCH de la (1995) Is there a correlation between prostate size and Bladder outlet obstruction? World J Urol 13: 9-13
24. 3. Urologe A 45: 585-864
25. Sullivan MP, Yalla SV (1996) Detrusor contractility and compliance characteristics in adult male patients with obstructive and nonobstructive voiding dysfunction. J Urol 155: 1995-2000
26. Styles RA, Ramsden PD, Neal DE (1991) The outcome of prostatectomy on chronic retention of urine. J Urol 146: 1029-1033
27. Tan A, Gilling P (2005) Lasers in the treatment of benign prostatic hyperpplasia: an update. Curr Opin Urol 15: 55-58
28. Te AE, Malloy TR, Stein BS et al. (2004) Photoselektive vaporisation of the prostate fort he treatment of benign prostatic hyperplasia: 12 month results from the first United States Multicenter Prospective Trial. J Urol 172: 1404-1408
29. Zwergel U, Wullich B, Lindenmeir U et al. (1998) Long-term results following transurethral resection of the prostate. Eur Urol 33: 476-480